Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > NAPEC: AWAITING A TAKEOVER OFFER

<< Previous

Bullboard Posts

Next >>

Comment by CBalardoon Oct 22, 2017 1:12am

100 Views

Post# 26841634

RE:RE:NAPEC: AWAITING A TAKEOVER OFFER

Well this is a great stock at the wrong time! The predict the stock market is about to go though some wobbly times in the next while. I bought this stock at .74 cents 1.05 and again at 1.12 but had to pull back my positions on this stock and two others. This will be the first stock I jump into once the markets especially the Dow jones settle out where they should be. I think this stock will shine and has great support. The only thing that will bring this under a buck is a major correction on markets. Good luck to you guys I may have missed out on some more profits but I hope to get back in again .It's good to see the board more active here as well.

<< Previous

Bullboard Posts

Next >>

Viva Gold brings new drill program and updated PEA to Nevada project